21 CFR §211.89
Verified against eCFR.gov as of June 20, 2026View official text on eCFR.gov ↗
Rejected components, drug product containers, and closures shall be identified and controlled under a quarantine system designed to prevent their use in manufacturing or processing operations for which they are unsuitable.